glp 1 stocks Hims & Hers Health stock plunged Monday after the U.S. Food and Drug Administration said it plans to take “decisive steps” against compounded -1 weight-loss drugs. Shares fell as much as 27% Best GLP-1 stocks: Lilly leads,

BPC 157 has caught attention because of its potential healing properties, particularly in tissues and muscles

Among the most promising developments is the use of GLP-1 (glucagon-like peptide-1) medications for weight loss

In a review published last year, Sikiric and his colleagues describe BPC-157 as a drug like no other: In animal models, it counteracts symptoms akin to those of Parkinsons, Alzheimers, and schizophrenia

In one study, these bacteria were found to reduce gas and flatulence in people with IBS (6) rhamnosus : Some research suggests that this strain may help manage stress through your gut-brain connection by positively influencing GABA, a neurotransmitter (7)